Michael D. Keller

7.9k total citations · 1 hit paper
91 papers, 3.5k citations indexed

About

Michael D. Keller is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Michael D. Keller has authored 91 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Immunology, 39 papers in Oncology and 38 papers in Epidemiology. Recurrent topics in Michael D. Keller's work include Cytomegalovirus and herpesvirus research (28 papers), Immunodeficiency and Autoimmune Disorders (25 papers) and CAR-T cell therapy research (21 papers). Michael D. Keller is often cited by papers focused on Cytomegalovirus and herpesvirus research (28 papers), Immunodeficiency and Autoimmune Disorders (25 papers) and CAR-T cell therapy research (21 papers). Michael D. Keller collaborates with scholars based in United States, Canada and Switzerland. Michael D. Keller's co-authors include David R. Jones, Marty W. Mayo, Roy A. Frye, Fan Yeung, Catherine M. Bollard, Chadrick E. Denlinger, Patrick J. Hanley, Brian K. Rundall, Soma Jyonouchi and Haili Lang and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and The EMBO Journal.

In The Last Decade

Michael D. Keller

84 papers receiving 3.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Modulation of NF‐κB‐dependent transcription and cell survival by the SIRT1 deacetylase

2004 2.3k citations Michael D. Keller et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael D. Keller United States	20	1.3k	1.1k	968	698	670	91	3.5k
Thomas A. White United States	34	528 0.4×	1.6k 1.4×	702 0.7×	2.1k 3.0×	655 1.0×	69	4.9k
Anthony J. Covarrubias United States	9	278 0.2×	1.2k 1.1×	366 0.4×	632 0.9×	912 1.4×	10	2.9k
Wenbo Zhang United States	29	256 0.2×	1.4k 1.2×	332 0.3×	540 0.8×	442 0.7×	98	3.4k
Raghavan Raju United States	30	278 0.2×	991 0.9×	594 0.6×	389 0.6×	445 0.7×	90	2.9k
Jaroslaw W. Zmijewski United States	40	140 0.1×	2.1k 1.8×	790 0.8×	618 0.9×	1.6k 2.3×	70	5.1k
Julia Skokowa Germany	24	179 0.1×	942 0.8×	297 0.3×	919 1.3×	1.4k 2.1×	107	3.5k
Ying Cui China	20	119 0.1×	1.7k 1.5×	2.3k 2.4×	563 0.8×	269 0.4×	57	4.4k
Pamela Fischer‐Posovszky Germany	38	216 0.2×	1.9k 1.6×	1.8k 1.9×	2.0k 2.8×	580 0.9×	121	4.9k
Gelsomina Mansueto Italy	32	78 0.1×	1.6k 1.4×	1.4k 1.4×	611 0.9×	265 0.4×	99	4.4k
Gunnar Cario Germany	31	88 0.1×	1.4k 1.2×	369 0.4×	702 1.0×	632 0.9×	126	4.3k

Countries citing papers authored by Michael D. Keller

Since Specialization

Citations

This map shows the geographic impact of Michael D. Keller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Keller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Keller more than expected).

Fields of papers citing papers by Michael D. Keller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Keller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Keller. The network helps show where Michael D. Keller may publish in the future.

Co-authorship network of co-authors of Michael D. Keller

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Keller. A scholar is included among the top collaborators of Michael D. Keller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Keller. Michael D. Keller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hanisch, Benjamin, et al.. (2025). Harnessing virus-specific T cells: expanding therapeutic strategies across diverse populations. Blood Advances. 9(23). 5965–5975. 1 indexed citations

Keller, Michael D., et al.. (2025). Predicting donor engraftment success in adults post haploidentical bone marrow transplant for sickle cell disease: BMT CTN 1507. Blood. 146(Supplement 1). 2472–2472.

Keller, Michael D., Stefan Schattgen, Shanmuganathan Chandrakasan, et al.. (2024). Secondary bone marrow graft loss after third-party virus-specific T cell infusion: Case report of a rare complication. Nature Communications. 15(1). 2749–2749. 3 indexed citations

Keller, Michael D., Jennifer Michlitsch, Paibel Aguayo‐Hiraldo, et al.. (2024). Development of a Safety Surveillance Plan for the Academic Medicine Sponsor Performing First-in-Human Cellular Therapy Clinical Trials: A Report from the Consortium for Pediatric Cellular Immunotherapy. Transplantation and Cellular Therapy. 30(5). 475–487. 1 indexed citations

Grimley, Michael, Tom Leemhuis, José A. Cancelas, et al.. (2024). Third-party virus-specific T cells for the treatment of double-stranded DNA viral reactivation and posttransplant lymphoproliferative disease after solid organ transplant. American Journal of Transplantation. 24(9). 1634–1643. 13 indexed citations

Kinoshita, Hiroshi, et al.. (2024). T CELL IMMUNE RESPONSE TO INFLUENZA VACCINATION WHEN ADMINISTERED BEFORE AND AFTER AUTOLOGOUS CAR-T CELL THERAPY. Cytotherapy. 26(6). S201–S202. 1 indexed citations

Sacco, Keith, Hye Sun Kuehn, Tomoki Kawai, et al.. (2022). A Heterozygous Gain-of-Function Variant in IKBKB Associated with Autoimmunity and Autoinflammation. Journal of Clinical Immunology. 43(2). 512–520. 6 indexed citations

Rubinstein, Jeremy D., Carolyn Lutzko, Tom Leemhuis, et al.. (2021). Scheduled Donor-Derived Viral Specific T-Cells for Prophylaxis Against Double Stranded DNA Viral Infection after Pediatric Allogeneic Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 27(3). S87–S88. 1 indexed citations

Rubinstein, Jeremy D., Sonata Jodele, Jamie Wilhelm, et al.. (2021). Off-the-Shelf Third-Party Virus-Specific T Cell Therapy to Treat JC Polyomavirus Infection in Hematopoietic Stem Cell Transplantation Recipients. Transplantation and Cellular Therapy. 28(2). 116.e1–116.e7. 17 indexed citations

10.

Kuehn, Hye Sun, Jennifer Stoddard, Julie E. Niemela, et al.. (2020). Recurrent lymphadenitis in a female XIAP/BIRC4 mutation carrier with normal lyonization. The Journal of Allergy and Clinical Immunology In Practice. 9(2). 1002–1005.e2. 1 indexed citations

11.

Lazarski, Christopher A., et al.. (2020). Identification of new cytokine combinations for antigen-specific T-cell therapy products via a high-throughput multi-parameter assay. Cytotherapy. 23(1). 65–76. 9 indexed citations

12.

Abraham, Allistair, Michael D. Keller, Carolina Colli Cruz, et al.. (2019). Safety and feasibility of virus-specific T cells derived from umbilical cord blood in cord blood transplant recipients. Blood Advances. 3(14). 2057–2068. 33 indexed citations

13.

Hanisch, Benjamin, Blachy J. Dávila Saldaña, Michael D. Keller, & Xiaoyan Song. (2018). High Rates of Community and Hospital Acquired Infections in Patients with Cellular Immunodeficiencies. Journal of Clinical Immunology. 38(7). 804–809. 2 indexed citations

14.

Cruz, Carolina Colli, Allison B. Powell, Haili Lang, et al.. (2018). Human papilloma virus–specific T cells can be generated from naïve T cells for use as an immunotherapeutic strategy for immunocompromised patients. Cytotherapy. 20(3). 385–393. 14 indexed citations

15.

Hanley, Patrick J., Michael D. Keller, Haili Lang, et al.. (2017). Clinical Use of CMV-Specific T Cells Derived from CMV-Naïve Donors. Blood. 130. 4470–4470. 1 indexed citations

16.

Keller, Michael D., Jaya Ganesh, Michele Paessler, et al.. (2013). Severe Combined Immunodeficiency Resulting From Mutations in MTHFD1. PEDIATRICS. 131(2). e629–e634. 35 indexed citations

17.

Heimall, Jennifer, Michael D. Keller, R. Saltzman, et al.. (2012). Diagnosis of 22q11.2 Deletion Syndrome and Artemis Deficiency in Two Children with T-B-NK+ Immunodeficiency. Journal of Clinical Immunology. 32(5). 1141–1144. 11 indexed citations

18.

Keller, Michael D., Peck Y. Ong, Joseph A. Church, et al.. (2011). Hypohidrotic Ectodermal Dysplasia and Immunodeficiency with Coincident NEMO and EDA Mutations. SHILAP Revista de lepidopterología. 2. 61–61. 19 indexed citations

19.

Goonewardena, Sascha N., John E. Blair, J. Matthew Brennan, et al.. (2009). Use of Hand Carried Ultrasound, B-type Natriuretic Peptide, and Clinical Assessment in Identifying Abnormal Left Ventricular Filling Pressures in Patients Referred for Right Heart Catheterization. Journal of Cardiac Failure. 16(1). 69–75. 42 indexed citations

20.

Keller, Michael D., et al.. (2006). The Effect of Natural Killer Cell Killer Ig-Like Receptor Alloreactivity on the Outcome of Bone Marrow Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID). Journal of Clinical Immunology. 27(1). 109–116. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact